XTL Biopharma (XTLB) Reports Q1 Loss of $0.01/Share

XTL Biopharma (NASDAQ: XTLB) reported Q1 EPS of ($0.01), versus $0.00 reported last year.

For earnings history and earnings-related data on XTL Biopharma (XTLB) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SanDisk upgraded at JPMorgan after investor day; shares climb
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c